Ajzenberg N - Search Results

1

Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy.

Ajzenberg N, Denis CV, Veyradier A, Girma JP, Meyer D, Baruch D. Ajzenberg N, et al. Thromb Haemost. 2002 May;87(5):808-11. Thromb Haemost. 2002. PMID: 12038781

2

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.

Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, Van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P; Working Group on Perioperative Haemostasis; French Study Group on Thrombosis and Haemostasis. Sié P, et al. Arch Cardiovasc Dis. 2011 Dec;104(12):669-76. doi: 10.1016/j.acvd.2011.09.001. Epub 2011 Oct 29. Arch Cardiovasc Dis. 2011. PMID: 22152517 Free article.

3

Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.

Baruch D, Ajzenberg N, Denis C, Legendre P, Lormeau JC, Meyer D. Baruch D, et al. Among authors: ajzenberg n. Thromb Haemost. 1994 Jan;71(1):141-6. Thromb Haemost. 1994. PMID: 8165633

4

Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen.

Denis C, Baruch D, Kielty CM, Ajzenberg N, Christophe O, Meyer D. Denis C, et al. Among authors: ajzenberg n. Arterioscler Thromb. 1993 Mar;13(3):398-406. doi: 10.1161/01.atv.13.3.398. Arterioscler Thromb. 1993. PMID: 8443144

5

Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor.

Depraetere H, Ajzenberg N, Girma JP, Lacombe C, Meyer D, Deckmyn H, Baruch D. Depraetere H, et al. Among authors: ajzenberg n. Blood. 1998 May 15;91(10):3792-9. Blood. 1998. PMID: 9573016 Free article.

6

Modulation by heparin of the interaction of the A1 domain of Von Willebrand factor with glycoprotein Ib.

Perrault C, Ajzenberg N, Legendre P, Rastegar-Lari G, Meyer D, Lopez JA, Baruch D. Perrault C, et al. Among authors: ajzenberg n. Blood. 1999 Dec 15;94(12):4186-94. Blood. 1999. PMID: 10590063 Free article.

7

Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation.

Ajzenberg N, Ribba AS, Rastegar-Lari G, Meyer D, Baruch D. Ajzenberg N, et al. Blood. 2000 Jun 15;95(12):3796-803. Blood. 2000. PMID: 10845912 Free article.

8

Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.

Cauwenberghs N, Ajzenberg N, Vauterin S, Hoylaerts MF, Declerck PJ, Baruch D, Deckmyn H. Cauwenberghs N, et al. Among authors: ajzenberg n. Haemostasis. 2000 May-Jun;30(3):139-48. doi: 10.1159/000022536. Haemostasis. 2000. PMID: 11014964

9

Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.

Rastegar-Lari G, Ajzenberg N, Ribba AS, Vereycken-Holler V, Legendre P, Villoutreix B, Meyer D, Baruch D. Rastegar-Lari G, et al. Among authors: ajzenberg n. Thromb Haemost. 2001 Dec;86(6):1459-65. Thromb Haemost. 2001. PMID: 11776314

10

von Willebrand factor binding to heparin in various types of von Willebrand disease.

Rastegar-Lari G, Legendre P, Ajzenberg N, Warszawski J, Meyer D, Baruch D. Rastegar-Lari G, et al. Among authors: ajzenberg n. Hematol J. 2000;1(3):190-8. doi: 10.1038/sj.thj.6200026. Hematol J. 2000. PMID: 11920189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters